Tenaya Therapeutics (TNYA) Cash from Operations (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Cash from Operations of 19234000.0 for Q1 2026, up 16.78% year-over-year from 16470404.15 in Q1 2025, and down 37.98% quarter-over-quarter from 13940000.0 in Q4 2025.
Tenaya Therapeutics (TNYA) Cash from Operations (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Cash from Operations history runs 7 years deep, the most recent figure standing at 19234000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 16.78% year-over-year to 19234000.0; the TTM figure through Mar 2026 stood at 64386000.0 (up 24.21% YoY), while the FY2025 annual figure was 68264000.0, up 24.57% from the prior year.
- Cash from Operations for Q1 2026 stood at 19234000.0, down from 13940000.0 in the prior quarter.
- The five-year high for Cash from Operations was 13940000.0 in Q4 2025, with the low at 30290000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 23112000.0 (2025), against an average of 22617352.94.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations slumped 111.58% in 2022, then soared 33.89% in 2025.
- Tenaya Therapeutics' Cash from Operations stood at 22682000.0 in 2022, then rose by 3.34% to 21924000.0 in 2023, then increased by 16.13% to 18388000.0 in 2024, then increased by 24.19% to 13940000.0 in 2025, then sank by 37.98% to 19234000.0 in 2026.
- Business Quant data shows TNYA's Cash from Operations at 19234000.0 in Q1 2026, 13940000.0 in Q4 2025, and 15599000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - | -3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.55 Mn |
| Jun 30, 2026 | -3.55 Mn |
| Mar 31, 2026 | -19.23 Mn |
| Mar 31, 2026 | -19.23 Mn |
| Dec 31, 2025 | -13.94 Mn |
| Dec 31, 2025 | -13.94 Mn |
| Sep 30, 2025 | -15.60 Mn |
| Sep 30, 2025 | -15.60 Mn |
| Jun 30, 2025 | -15.61 Mn |
| Jun 30, 2025 | -15.61 Mn |
| Mar 31, 2025 | -23.11 Mn |
| Mar 31, 2025 | -23.11 Mn |
| Dec 31, 2024 | -18.39 Mn |
| Dec 31, 2024 | -18.39 Mn |
| Sep 30, 2024 | -19.84 Mn |
| Sep 30, 2024 | -19.84 Mn |
| Jun 30, 2024 | -23.62 Mn |
| Jun 30, 2024 | -23.62 Mn |
| Mar 31, 2024 | -28.66 Mn |
| Mar 31, 2024 | -28.66 Mn |